Melatonin inhibits voltage-sensitive Ca(2+) channel-mediated neurotransmitter release

Brain Res. 2014 Apr 4:1557:34-42. doi: 10.1016/j.brainres.2014.02.023. Epub 2014 Feb 18.

Abstract

Melatonin is involved in various neuronal functions such as circadian rhythmicity and thermoregulation. Melatonin has a wide range of pharmacologically effective concentration levels from the nanomolar to millimolar levels. Recently, the antiepileptic effect of high dose melatonin has been the focus of clinical studies; however, its detailed mechanism especially in relation to neurotransmitter release and synaptic transmission remains unclear. We studied the effect of melatonin at high concentrations on the neurotransmitter release by monitoring norepinephrine release in PC12 cells, and excitatory postsynaptic potential in rat hippocampal slices. Melatonin inhibits the 70mM K(+)-induced Ca(2+) increase at millimolar levels without effect on bradykinin-triggered Ca(2+) increase in PC12 cells. Melatonin (1mM) did not affect A2A adenosine receptor-evoked cAMP production, and classical melatonin receptor antagonists did not reverse the melatonin-induced inhibitory effect, suggesting G-protein coupled receptor independency. Melatonin inhibits the 70mM K(+)-induced norepinephrine release at a similar effective concentration range in PC12 cells. We confirmed that melatonin (100µM) inhibits excitatory synaptic transmission of the hippocampal Schaffer collateral pathway with the decrease in basal synaptic transmission and the increase in paired pulse ratio. These results show that melatonin inhibits neurotransmitter release through the blocking of voltage-sensitive Ca(2+) channels and suggest a possible mechanism for the antiepileptic effect of melatonin.

Keywords: Epilepsy; Excitatory synaptic transmission; Melatonin; Neurotransmitter release; Receptor-independent manner; Voltage-sensitive Ca(2+) channel.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / metabolism
  • Calcium Channel Blockers / pharmacology*
  • Calcium Channels / metabolism
  • Cyclic AMP / metabolism
  • Electric Stimulation
  • Excitatory Postsynaptic Potentials / drug effects
  • HEK293 Cells
  • Hippocampus / drug effects*
  • Hippocampus / physiology
  • Humans
  • In Vitro Techniques
  • Melatonin / pharmacology*
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Norepinephrine / metabolism
  • PC12 Cells
  • Patch-Clamp Techniques
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Adenosine A2A / metabolism
  • Receptors, Melatonin / agonists
  • Receptors, Melatonin / antagonists & inhibitors
  • Receptors, Melatonin / metabolism
  • Synaptic Transmission / drug effects
  • Synaptic Transmission / physiology

Substances

  • Calcium Channel Blockers
  • Calcium Channels
  • Receptor, Adenosine A2A
  • Receptors, Melatonin
  • Cyclic AMP
  • Melatonin
  • Calcium
  • Norepinephrine